Patents by Inventor Quet F. Ahkong

Quet F. Ahkong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7452550
    Abstract: This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: November 18, 2008
    Assignee: Hana Biosciences, Inc.
    Inventors: Thomas D. Madden, Sean C. Semple, Quet F. Ahkong
  • Patent number: 7311924
    Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: December 25, 2007
    Assignee: Hana Biosciences, Inc.
    Inventors: Andreas H Sarris, Fernando Cabanillas, Patricia M Logan, Clive T R Burge, James H Goldie, Murray S Webb, Thomas D Madden, Sean C Semple, Quet F Ahkong, Sandra K Klimuk
  • Patent number: 7244448
    Abstract: This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: July 17, 2007
    Assignee: Tekmira Pharmaceuticals Corporation
    Inventors: Thomas D. Madden, Sean C. Semple, Quet F. Ahkong
  • Publication number: 20040170678
    Abstract: This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
    Type: Application
    Filed: February 27, 2004
    Publication date: September 2, 2004
    Applicant: Inex Pharmaceuticals Corporation
    Inventors: Thomas D. Madden, Sean C. Semple, Quet F. Ahkong
  • Publication number: 20040071768
    Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.
    Type: Application
    Filed: April 3, 2003
    Publication date: April 15, 2004
    Applicants: Inex Pharmaceuticals Corporation, The University of Texas, MD Anderson Cancer Center
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb, Thomas D. Madden, Sean C. Semple, Quet F. Ahkong, Sandra K. Klimuk
  • Publication number: 20020110586
    Abstract: This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
    Type: Application
    Filed: June 29, 2001
    Publication date: August 15, 2002
    Applicant: Inex Pharmaceuticals Corporation
    Inventors: Thomas D. Madden, Sean C. Semple, Quet F. Ahkong